Related Experiment Video
Updated: Jul 9, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Effectiveness of a Maintenance and Reliever Digihaler System in Asthma: 24-Week Randomized Study (CONNECT2)
Giselle S Mosnaim1, Flavia C L Hoyte2, Guilherme Safioti3
1Division of Pulmonary, Allergy and Critical Care, Department of Medicine, NorthShore University Health System, Evanston, Ill.
The Digihaler System (DS) improved asthma control in patients compared to standard care. This digital health tool enhances inhaler technique and adherence, leading to better asthma management.
Area of Science:
- Digital health
- Asthma management
- Respiratory medicine
Background:
- Digital health tools can improve asthma control by addressing inhaler technique, adherence, and medication overuse.
- The Digihaler System (DS) includes inhalers, an app, and a dashboard for monitoring and clinical decision-making.
Purpose of the Study:
- To evaluate the effectiveness of the Digihaler System (DS) in improving asthma control compared to standard-of-care (SoC).
Main Methods:
- A 24-week, open-label, randomized study comparing DS to SoC in participants aged 13+ with uncontrolled asthma (ACT score <19).
- Primary endpoint: proportion of patients achieving well-controlled asthma (ACT score ≥20 or increase of ≥3 units).
Main Results:
- DS showed an 88.7% probability of improving asthma control versus SoC, with a 35% higher odds of improvement.
- DS group demonstrated increased clinician interactions, improved maintenance treatment adherence, and a 38.2% reduction in reliever use.
- App and Dashboard usability was rated as "good" by participants.
Conclusions:
- The Digihaler System (DS) effectively improves asthma control and adherence in patients with uncontrolled asthma.
- Digital health solutions like DS offer a promising approach to enhance asthma management and patient outcomes.
More Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
04:59Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
Related Concept Videos
Inhaled Medications
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...